PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MKGAF vs. VNRA.DE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between MKGAF and VNRA.DE is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

MKGAF vs. VNRA.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Merck KGaA (MKGAF) and Vanguard FTSE North America UCITS ETF (USD) Accumulating (VNRA.DE). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%SeptemberOctoberNovemberDecember2025February
-23.96%
13.36%
MKGAF
VNRA.DE

Key characteristics

Sharpe Ratio

MKGAF:

-0.30

VNRA.DE:

2.18

Sortino Ratio

MKGAF:

-0.15

VNRA.DE:

3.00

Omega Ratio

MKGAF:

0.98

VNRA.DE:

1.43

Calmar Ratio

MKGAF:

-0.27

VNRA.DE:

3.35

Martin Ratio

MKGAF:

-0.81

VNRA.DE:

15.04

Ulcer Index

MKGAF:

15.32%

VNRA.DE:

1.84%

Daily Std Dev

MKGAF:

41.93%

VNRA.DE:

12.67%

Max Drawdown

MKGAF:

-45.57%

VNRA.DE:

-34.48%

Current Drawdown

MKGAF:

-45.57%

VNRA.DE:

0.00%

Returns By Period

In the year-to-date period, MKGAF achieves a -9.31% return, which is significantly lower than VNRA.DE's 4.29% return.


MKGAF

YTD

-9.31%

1M

-3.26%

6M

-23.96%

1Y

-16.32%

5Y*

1.85%

10Y*

6.11%

VNRA.DE

YTD

4.29%

1M

3.79%

6M

20.84%

1Y

27.61%

5Y*

15.32%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MKGAF vs. VNRA.DE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MKGAF
The Risk-Adjusted Performance Rank of MKGAF is 2929
Overall Rank
The Sharpe Ratio Rank of MKGAF is 3030
Sharpe Ratio Rank
The Sortino Ratio Rank of MKGAF is 2828
Sortino Ratio Rank
The Omega Ratio Rank of MKGAF is 2828
Omega Ratio Rank
The Calmar Ratio Rank of MKGAF is 2929
Calmar Ratio Rank
The Martin Ratio Rank of MKGAF is 2828
Martin Ratio Rank

VNRA.DE
The Risk-Adjusted Performance Rank of VNRA.DE is 8787
Overall Rank
The Sharpe Ratio Rank of VNRA.DE is 8787
Sharpe Ratio Rank
The Sortino Ratio Rank of VNRA.DE is 8686
Sortino Ratio Rank
The Omega Ratio Rank of VNRA.DE is 8989
Omega Ratio Rank
The Calmar Ratio Rank of VNRA.DE is 8686
Calmar Ratio Rank
The Martin Ratio Rank of VNRA.DE is 8989
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MKGAF vs. VNRA.DE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Merck KGaA (MKGAF) and Vanguard FTSE North America UCITS ETF (USD) Accumulating (VNRA.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MKGAF, currently valued at -0.41, compared to the broader market-2.000.002.004.00-0.412.00
The chart of Sortino ratio for MKGAF, currently valued at -0.36, compared to the broader market-6.00-4.00-2.000.002.004.00-0.362.76
The chart of Omega ratio for MKGAF, currently valued at 0.96, compared to the broader market0.501.001.502.000.961.38
The chart of Calmar ratio for MKGAF, currently valued at -0.38, compared to the broader market0.002.004.006.00-0.383.08
The chart of Martin ratio for MKGAF, currently valued at -1.10, compared to the broader market0.0010.0020.0030.00-1.1012.22
MKGAF
VNRA.DE

The current MKGAF Sharpe Ratio is -0.30, which is lower than the VNRA.DE Sharpe Ratio of 2.18. The chart below compares the historical Sharpe Ratios of MKGAF and VNRA.DE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
-0.41
2.00
MKGAF
VNRA.DE

Dividends

MKGAF vs. VNRA.DE - Dividend Comparison

MKGAF's dividend yield for the trailing twelve months is around 1.71%, more than VNRA.DE's 0.25% yield.


TTM20242023202220212020201920182017201620152014
MKGAF
Merck KGaA
1.71%1.55%1.50%1.03%0.65%0.85%1.20%1.48%1.21%1.14%1.11%1.37%
VNRA.DE
Vanguard FTSE North America UCITS ETF (USD) Accumulating
0.25%0.26%0.00%0.00%0.00%0.89%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

MKGAF vs. VNRA.DE - Drawdown Comparison

The maximum MKGAF drawdown since its inception was -45.57%, which is greater than VNRA.DE's maximum drawdown of -34.48%. Use the drawdown chart below to compare losses from any high point for MKGAF and VNRA.DE. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-45.57%
-0.71%
MKGAF
VNRA.DE

Volatility

MKGAF vs. VNRA.DE - Volatility Comparison

Merck KGaA (MKGAF) has a higher volatility of 12.65% compared to Vanguard FTSE North America UCITS ETF (USD) Accumulating (VNRA.DE) at 4.50%. This indicates that MKGAF's price experiences larger fluctuations and is considered to be riskier than VNRA.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%SeptemberOctoberNovemberDecember2025February
12.65%
4.50%
MKGAF
VNRA.DE
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab